305821-96-9|CP-472555|2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-7-hydroxy-4b-(phenylmethyl)-7-(1-propyn-1-yl)-N-(3-pyridinylmethyl)-, (4bS,7R,8aR)-|-范德生物科技公司

CP-472555

NMR下载 COA and HPLC MSDS下载
names：
2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-7-hydroxy-4b-(phenylmethyl)-7-(1-propyn-1-yl)-N-(3-pyridinylmethyl)-, (4bS,7R,8aR)-
CAS号：
305821-96-9
MDL Number：
MF(分子式)： C31H32N2O2 MW(分子量)： 464.6
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	CP-472555
英文别名	CP-472555; CP 472555; CP472555; UNII-6T0KV7024R.
CAS号	305821-96-9
Inchi	InChI=1S/C31H32N2O2/c1-2-14-30(35)15-16-31(19-23-7-4-3-5-8-23)27(20-30)12-10-25-18-26(11-13-28(25)31)29(34)33-22-24-9-6-17-32-21-24/h3-9,11,13,17-18,21,27,35H,10,12,15-16,19-20,22H2,1H3,(H,33,34)/t27-,30-,31+/m1/s1
InchiKey	SEOPOTXFVGEDGX-UPHHSBJESA-N
分子式 Formula	C31H32N2O2
分子量 Molecular Weight	464.6
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	CP-472555(CAS:305821-96-9):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	CP-472555 is a selective, nonsteroidal glucocorticoid receptor antagonist, with anti-GR and anti-obesity activity in animal models.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Briski KP, Kale AY, Vavaiya KV. Impact of recurring intermediate insulin-induced hypoglycemia on hypothalamic paraventricular corticotropin-releasing hormone, oxytocin, vasopressin and glucokinase gene profiles: role of type II glucocorticoid receptors. Exp Brain Res. 2009 Jun;195(4):499-507. doi: 10.1007/s00221-009-1787-4. Epub 2009 May 6. PubMed PMID: 19418044.

[2]Kale AY, Paranjape SA, Briski KP. Type II glucocorticoid receptor involvement in habituated activation of lateral hypothalamic area orexin-A-immunopositive neurons during recurring insulin-induced hypoglycemia. Neurosci Res. 2006 Nov;56(3):309-13. Epub 2006 Sep 25. PubMed PMID: 16997409.

[3] Kale AY, Vavaiya KV, Briski KP. Effects of acute and chronic insulin-induced hypoglycemia on type II glucocorticoid receptor (GR) gene expression in characterized CNS metabolic loci. Brain Res Bull. 2006 Jul 31;70(3):240-4. Epub 2006 Jun 6. PubMed PMID: 16861109.

[4] Kale AY, Paranjape SA, Briski KP. Site-specific habituation of insulin-induced hypoglycemic induction of fos immunoreactivity in glucocorticoid receptor: immunopositive neurons in the male rat brain. Exp Brain Res. 2007 Jan;176(2):260-6. PubMed PMID: 16850320.

[5] Kale AY, Paranjape SA, Briski KP. I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration. Neuroscience. 2006 Jun 30;140(2):555-65. Epub 2006 Apr 19. PubMed PMID: 16626867.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开